help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Durlach, A.
Right arrow Articles by Durlach, V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Durlach, A.
Right arrow Articles by Durlach, V.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 10 3656-3659
Copyright © 1999 by The Endocrine Society


Original Studies

Sex-Dependent Association of a Genetic Polymorphism of Cholesteryl Ester Transfer Protein with High-Density Lipoprotein Cholesterol and Macrovascular Pathology in Type II Diabetic Patients

Anne Durlach, Christine Clavel, Anik Girard-Globa and Vincent Durlach

Institut Pol Bouin (A.D., C.C.), Hôpital Maison Blanche, Centre Hospitalo-Universitaire, 51092 Reims; Laboratoire de Métabolisme des Lipides (A.G.-G.), Hôpital de l’Antiquaille and CNRS UPRESA 5014, 69005 Lyon; Service d’Endocrinologie (V.D.), Maladies Métabolique et de Médecine Interne, Hôpital Robert Debré, Centre Hospitalo-Universitaire, 51092 Reims, France

Address all correspondence and requests for reprints to: Dr. Anne Durlach, Institut Pol Bouin, Hôpital Maison Blanche, Centre Hospitalo-Universitaire, 51092 Reims, France.

Cholesterol ester transfer protein (CETP) is a key regulating factor of lipid metabolism, and the polymorphism of its gene may be a candidate for modulating the lipid parameters in type 2 diabetic subjects. In a group of 406 type 2 diabetic patients aged 59.5 ± 10.8 y, with a body mass index of 28.9 ± 5.3 kg/m2 and HbA1c = 8.2 ± 1.9%, we studied the B polymorphism at the CETP locus detectable with the restriction enzyme TaqI. Patients were separated into groups, 231 males (78 B1B1, 108 B1B2, 45 B2B2) and 175 females (48 B1B1, 94 B1B2, 33 B2B2), and compared on the basis of their lipid parameters (total cholesterol, triglycerides, high-density lipoprotein-cholesterol (HDL-C), ApoA1 ApoB, and low-density lipoprotein-cholesterol), their micro and macrovascular complications. HDL-C was significantly higher in man with the B2B2 genotype (respectively, 1.31 ± 0.44 mmol/L vs. 1.13 ± 0.32 mmol/L, P < 0.05), together with a lower incidence of coronary heart disease (9 vs. 25% for B1B1 and B1B2 together). Women displayed a higher HDL-C than men and a equally high incidence of coronary heart disease in B2 homozygotes as in other genotypes (26 vs. 27%). Thus, in type 2 diabetic patients, Taq1b polymorphism seems to exert a modulating role in males only. This may contribute to the loss of macrovascular protection in type 2 diabetic females.




This article has been cited by other articles:


Home page
Diabetes CareHome page
I. Porchay-Balderelli, F. Pean, N. Bellili, R. Jaziri, M. Marre, F. Fumeron, and for the DIABHYCAR Study Group
The CETP TaqIB Polymorphism Is Associated With the Risk of Sudden Death in Type 2 Diabetic Patients
Diabetes Care, November 1, 2007; 30(11): 2863 - 2867.
[Abstract] [Full Text] [PDF]


Home page
JAMAHome page
N. A. Patsopoulos, A. Tatsioni, and J. P. A. Ioannidis
Claims of Sex Differences: An Empirical Assessment in Genetic Associations
JAMA, August 22, 2007; 298(8): 880 - 893.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
J. E. Kanter, F. Johansson, R. C. LeBoeuf, and K. E. Bornfeldt
Do Glucose and Lipids Exert Independent Effects on Atherosclerotic Lesion Initiation or Progression to Advanced Plaques?
Circ. Res., March 30, 2007; 100(6): 769 - 781.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
S. M. Boekholdt and J. F. Thompson
Natural genetic variation as a tool in understanding the role of CETP in lipid levels and disease
J. Lipid Res., July 1, 2003; 44(6): 1080 - 1093.
[Abstract] [Full Text] [PDF]


Home page
Diabetes CareHome page
F. V. van Venrooij, R. P. Stolk, J.-D. Banga, T. P. Sijmonsma, A. van Tol, D. W. Erkelens, and G. M. Dallinga-Thie
Common Cholesteryl Ester Transfer Protein Gene Polymorphisms and the Effect of Atorvastatin Therapy in Type 2 Diabetes
Diabetes Care, April 1, 2003; 26(4): 1216 - 1223.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M.C. Mahaney, L. Almasy, D.L. Rainwater, J.L. VandeBerg, S.A. Cole, J.E. Hixson, J. Blangero, and J.W. MacCluer
A Quantitative Trait Locus on Chromosome 16q Influences Variation in Plasma HDL-C Levels in Mexican Americans
Arterioscler Thromb Vasc Biol, February 1, 2003; 23(2): 339 - 345.
[Abstract] [Full Text] [PDF]


Home page
British Journal of Diabetes & Vascular DiseaseHome page
L. Iacoviello, E. Ciccarone, and M. B. Donati
Review: The genetics of macrovascular disease in diabetes
The British Journal of Diabetes & Vascular Disease, September 1, 2002; 2(5): 364 - 368.
[Abstract] [PDF]


Home page
DiabetesHome page
I. Kawasaki, H. Tahara, M. Emoto, T. Shoji, and Y. Nishizawa
Relationship Between TaqIB Cholesteryl Ester Transfer Protein Gene Polymorphism and Macrovascular Complications in Japanese Patients With Type 2 Diabetes
Diabetes, March 1, 2002; 51(3): 871 - 874.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1999 by The Endocrine Society